Conditions: Soft Tissue Sarcoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 128
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the therapeutic activity and safety of E7389 in patients with advanced/metastatic soft tissue sarcoma who have failed standard chemotherapy.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: E7389
Intervention descriptions: intervention 1: 1.4 mg/m\^2 administered as an intravenous (I.V.) bolus infusion on Days 1 and 8 of every 21 days.

Protocol document: